Your browser doesn't support javascript.
loading
Efficacy, Safety, and Immunogenicity of Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Compared with Originator Insulin Aspart Mix 70/30 in Adults with Diabetes (GEMELLI M): A Subgroup Analysis by Prior Type of Premix Insulin.
Aravind, S R; Singh, Kiran P; Mogylnytska, Liliia; Zalevskaya, Alsu G; Matyjaszek-Matuszek, Beata; Wernicke-Panten, Karin; Nguyên-Pascal, My-Liên; Pierre, Suzanne; Rotthaeuser, Baerbel; Kramer, Daniel; Mukherjee, Bhaswati.
Afiliação
  • Aravind SR; Diabetes Care and Research Center, Diacon Hospital, Bangalore, India.
  • Singh KP; Columbia Asia Hospital, Bangalore, India.
  • Mogylnytska L; Department of Endocrinology, Fortis Hospital Mohali, Chandigarh, India.
  • Zalevskaya AG; Khmelnytskyi Regional Hospital, Khmelnytskyi, Ukraine.
  • Matyjaszek-Matuszek B; Department of Endocrinology, First Pavlov State Medical University, St. Petersburg, Russia.
  • Wernicke-Panten K; Department of Endocrinology, Medical University of Lublin, Lublin, Poland.
  • Nguyên-Pascal ML; Sanofi, Frankfurt, Germany.
  • Pierre S; Sanofi Research and Development, Chilly-Mazarin, France.
  • Rotthaeuser B; Sanofi Research and Development, Chilly-Mazarin, France.
  • Kramer D; Sanofi, Frankfurt, Germany.
  • Mukherjee B; Sanofi, Frankfurt, Germany.
Diabetes Ther ; 13(7): 1299-1310, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35650350
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Diabetes Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Diabetes Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia